PAXMAN AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.5 SEK | -0.79% |
|
+6.84% | +1.90% |
| 01-15 | Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
| Sales 2023 | 210M 19.24M 1.53B | Sales 2024 * | 292M 26.74M 2.13B | Capitalization | 719M 65.8M 5.24B |
|---|---|---|---|---|---|
| Net income 2023 | 8M 732K 58.32M | Net income 2024 * | 34M 3.11M 248M | EV / Sales 2023 | 3.33 x |
| Net cash position 2023 * | 19M 1.74M 139M | Net cash position 2024 * | 42M 3.85M 306M | EV / Sales 2024 * | 2.32 x |
| P/E ratio 2023 |
83.6
x | P/E ratio 2024 * |
21
x | Employees | 91 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 36.29% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.79% | ||
| 1 week | +6.84% | ||
| 1 month | +2.46% | ||
| 3 months | +1.35% | ||
| 6 months | +36.36% | ||
| Current year | +1.90% |
1 week
34.00
38.70
1 month
34.0038.70
Current year
32.0039.70
1 year
22.0039.70
3 years
22.0074.40
5 years
18.0074.40
10 years
9.5574.40
| Managers | Title | Age | Since |
|---|---|---|---|
Richard Paxman
CEO | Chief Executive Officer | 41 | 19/12/16 |
| Director of Finance/CFO | 44 | 29/02/20 | |
Patrick Burke
CTO | Chief Tech/Sci/R&D Officer | 65 | 31/12/08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Björn Littorin
BRD | Director/Board Member | 77 | 30/11/16 |
| Chairman | 70 | 30/11/16 | |
Maria Bech
BRD | Director/Board Member | 56 | 19/12/16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 37.5 | -0.79% | 14 530 |
| 26/04/24 | 37.8 | +6.78% | 66,563 |
| 25/04/24 | 35.4 | +2.31% | 133 |
| 24/04/24 | 34.6 | +0.29% | 293 |
| 23/04/24 | 34.5 | -1.71% | 12,944 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 04:29 pm
More quotes
Paxman AB (publ) is a Sweden-based developer of scalp cooling technology. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The Company offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Companyâs primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.
Calendar
22/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
D
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.90% | 65.55M | |
| -2.79% | 187B | |
| -2.09% | 106B | |
| -4.50% | 66.9B | |
| +0.81% | 49.45B | |
| +16.62% | 48B | |
| +4.06% | 40.84B | |
| +3.45% | 26.48B | |
| +1.04% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- PAX Stock
